Mike Sharland
Datos Biográficos
| ID | 9006752 |
|---|---|
| NOMBRE | Mike Sharland |
| NOMBRES | Mike |
| APELLIDO | Sharland |
| FIRMA | SHARLAND M |
| AFILIACIONES | St George's, University of London |
| ORCID | 0000-0001-8626-8291 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
AWaRe antibiotic prescribing for common acute infections in private primary care in low–middle-income countries
BACKGROUNDS: There is limited high-quality data on antibiotic prescribing in low and middle-income countries, particularly in the private sector. Here, we use large-scale healthcare surveys to assess antibiotic prescribing levels and the factors influencing prescribing decisions for common infections in primary care and outpatient settings, predominantly within the private sector, in Pakistan, Egypt and Indonesia. METHODS: We analysed surveys com…
Reserve antibiotics
New antibiotics active against multidrug resistant bacteria (MDR-B) are licensed by regulatory agencies based on pivotal trials that serve the primary purpose of obtaining marketing-authorization. There is increasing concern that they do not offer guidance on how to best use new antibiotics, in which population, and to what extent they overcome existing resistance. We reviewed the literature for pre-approval studies (phase 2 and 3 randomized cont…
Global burden of bacterial antimicrobial resistance in 2019
BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…
Sin obras prominentes en esta página.
Global burden of bacterial antimicrobial resistance in 2019
BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…
Reserve antibiotics
New antibiotics active against multidrug resistant bacteria (MDR-B) are licensed by regulatory agencies based on pivotal trials that serve the primary purpose of obtaining marketing-authorization. There is increasing concern that they do not offer guidance on how to best use new antibiotics, in which population, and to what extent they overcome existing resistance. We reviewed the literature for pre-approval studies (phase 2 and 3 randomized cont…
AWaRe antibiotic prescribing for common acute infections in private primary care in low–middle-income countries
BACKGROUNDS: There is limited high-quality data on antibiotic prescribing in low and middle-income countries, particularly in the private sector. Here, we use large-scale healthcare surveys to assess antibiotic prescribing levels and the factors influencing prescribing decisions for common infections in primary care and outpatient settings, predominantly within the private sector, in Pakistan, Egypt and Indonesia. METHODS: We analysed surveys com…
Antibiotic Use and Resistance (3 obras) · Antibiotic Resistance in Bacteria (2 obras) · Antibiotics (2 obras) · Biology (2 obras) · Intensive care medicine (2 obras) · Medicine (2 obras) · Antibiotic resistance (1 obras) · Antibiotics Pharmacokinetics and Efficacy (1 obras) · Bioinformatics (1 obras) · Business (1 obras)